79 related articles for article (PubMed ID: 37575772)
1. One-year Outcomes of Biodegradable Polymer-coated Sirolimus-eluting Coronary Stent in Acute Coronary Syndrome - A Patient-level Pooled Analysis from Two Indian Registries.
Pothineni RB; Ajmera P; Chawla KK; Mantravadi SS; Pathak A; Inamdar MK; Jariwala PV; Vijan V; Vijan V; Potdar A
Cardiology; 2024 May; ():. PubMed ID: 38714182
[TBL] [Abstract][Full Text] [Related]
2. The Outcome of Ultrathin-Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Coronary Artery Disease Patients - A Feasibility Study.
Panduranga P; Mohammed A
Heart Views; 2023; 24(1):1-5. PubMed ID: 37124429
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials.
Zhu P; Zhou X; Zhang C; Li H; Zhang Z; Song Z
BMC Cardiovasc Disord; 2018 Aug; 18(1):170. PubMed ID: 30111289
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials.
Pilgrim T; Rothenbühler M; Siontis GC; Kandzari DE; Iglesias JF; Asami M; Lefèvre T; Piccolo R; Koolen J; Saito S; Slagboom T; Muller O; Waksman R; Windecker S
Am Heart J; 2021 May; 235():140-148. PubMed ID: 33609498
[TBL] [Abstract][Full Text] [Related]
5. Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stents: Patient-Level Pooled Analysis From Two Indian Registries.
Babu Pothineni R; Ajmera P; Chawla KK; Mantravadi SS; Pathak A; Inamdar MK; Jariwala PV; Vijan V; Vijan V; Potdar A
Cureus; 2023 Jul; 15(7):e41743. PubMed ID: 37575772
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents in an All-Comers Patient Population: 1-Year Results of the S-FLEX Slovakia Registry.
Hudec M; Kupec A; Gazdic P
Anatol J Cardiol; 2024 Mar; 28(3):142-149. PubMed ID: 38419511
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T
Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of an ultrathin-strut sirolimus-eluting stent in all-comers population: Thailand Orsiro registry.
Suwannasom P; Athiksakul S; Thonghong T; Lertsuwunseri V; Chaipromprasit J; Srimahachota S; Udayachalerm W; Kuanprasert S; Buddhari W
BMC Cardiovasc Disord; 2021 Oct; 21(1):501. PubMed ID: 34656088
[TBL] [Abstract][Full Text] [Related]
9. Twelve months clinical outcomes of ultrathin strut sirolimus-eluting stent in real-world Indian patients with coronary artery disease.
Ajmera P; Pothineni R; Chawla KK; Mantravadi SS; Jariwala P; Vijan V; Vijan V
Am J Cardiovasc Dis; 2022; 12(5):262-271. PubMed ID: 36419862
[TBL] [Abstract][Full Text] [Related]
10. Twelve-month clinical outcomes of "nano-crush technique" for the treatment of bifurcation lesions using ultra-thin (60 µm) sirolimus-eluting coronary stents.
Sinha SK; Kumar P; Pandey U; Aggarwal P; Razi M; Sharma AK; Jha M; Sachan M; Shukla P; Thakur R; Krishna V; Mukherjee P; Karmakar S; Bhattacharjee P; Ray S
Minerva Cardiol Angiol; 2023 Feb; 71(1):51-60. PubMed ID: 35212507
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of ultrathin biodegradable polymer-coated sirolimus-eluting stents in an all-comer population: One-year results from the T-FLEX registry including high-risk subgroups.
Pothineni RB; Vijan V; Potdar A; Inamdar MK; Pathak A; Mantravadi SS; Ajmera P
Anatol J Cardiol; 2021 Oct; 25(10):706-715. PubMed ID: 34622785
[TBL] [Abstract][Full Text] [Related]
12. Ultrathin (60 μm), ultralong (≥40 mm) sirolimus-eluting stent: study of clinical and safety profiles among real-world patients.
Sinha SK; Aggarwal P; Pandey U; Razi M; Kumar A; Krishna V
Anatol J Cardiol; 2021 Feb; 25(2):111-119. PubMed ID: 33583818
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
